Your browser doesn't support javascript.
loading
Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
Emad, Basant; WalyEldeen, Amr Ahmed; Hassan, Hebatallah; Sharaky, Marwa; Abdelhamid, Ismail A; Ibrahim, Sherif Abdelaziz; Mohamed, Hanan Rh.
Afiliação
  • Emad B; Biotechnology/Biomolecular Chemistry program, Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.
  • WalyEldeen AA; Department of Zoology, Faculty of Science, Cairo University, Giza, 12613, Egypt.
  • Hassan H; Department of Zoology, Faculty of Science, Cairo University, Giza, 12613, Egypt.
  • Sharaky M; Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, 11796, Egypt.
  • Abdelhamid IA; Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.
  • Ibrahim SA; Department of Zoology, Faculty of Science, Cairo University, Giza, 12613, Egypt. isherif@cu.edu.eg.
  • Mohamed HR; Department of Zoology, Faculty of Science, Cairo University, Giza, 12613, Egypt. hananeeyra@cu.edu.eg.
BMC Cancer ; 23(1): 1151, 2023 Nov 27.
Article em En | MEDLINE | ID: mdl-38012585
BACKGROUND: Triple-negative breast cancer (TNBC) is a lethal mammary carcinoma subtype that affects females and is associated with a worse prognosis. Chemotherapy is the only conventional therapy available for patients with TNBC due to the lack of therapeutic targets. Yttrium oxide (Y2O3) is a rare earth metal oxide, whose nanoparticle (NPs) formulations are used in various applications, including biological imaging, the material sciences, and the chemical synthesis of inorganic chemicals. However, the biological activity of Y2O3-NPs against TNBC cells has not been fully explored. The current study was conducted to assess Y2O3-NPs' anticancer activity against the human TNBC MDA-MB-231 cell line. METHODS: Transmission electron microscopy (TEM), X-ray diffraction, Zeta potential, and dynamic light scattering (DLS) were used to characterize the Y2O3-NPs. SRB cell viability, reactive oxygen species (ROS) measurement, single-cell gel electrophoresis (comet assay), qPCR, flow cytometry, and Western blot were employed to assess the anticancer activity of the Y2O3-NPs. RESULTS: Our results indicate favorable physiochemical properties of Y2O3-NPs (with approximately average size 14 nm, Zeta Potential about - 53.2 mV, and polydispersity index = 0.630). Y2O3-NPs showed a potent cytotoxic effect against MDA-MB-231 cells, with IC50 values of 74.4 µg/mL, without cytotoxic effect on the normal retina REP1 and human dermal fibroblast HDF cell lines. Further, treatment of MDA-MB-231 cells with IC50 Y2O3-NPs resulted in increased oxidative stress, accumulation of intracellular ROS levels, and induced DNA damage assessed by Comet assay. Upon Y2O3-NPs treatment, a significant increase in the early and late phases of apoptosis was revealed in MDA-MB-231 cells. qPCR results showed that Y2O3-NPs significantly upregulated the pro-apoptotic genes CASP3 and CASP8 as well as ferroptosis-related gene heme oxygenase-1 (HO-1), whereas the anti-apoptotic gene BCL2 was significantly downregulated. CONCLUSION: This study suggests that Y2O3-NPs are safe on normal REP1 and HDF cells and exhibited a potent selective cytotoxic effect against the TNBC MDA-MB-231 cells through increasing levels of ROS generation with subsequent DNA damage, and induction of apoptosis and ferroptosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias de Mama Triplo Negativas / Ferroptose Limite: Female / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias de Mama Triplo Negativas / Ferroptose Limite: Female / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito País de publicação: Reino Unido